- Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis
Jeayeon Park et al, 2024, Journal of Liver Cancer CrossRef - Dynamics of the neutrophil‑to‑lymphocyte ratio during lenvatinib treatment for unresectable hepatocellular carcinoma
Akifumi Kuwano et al, 2024, Oncology Letters CrossRef - The molecular mechanism of actions and clinical utilities of tumor infiltrating lymphocytes in gastrointestinal cancers: a comprehensive review and future prospects toward personalized medicine
Moein Piroozkhah et al, 2023, Frontiers in Immunology CrossRef - Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice
Kenta Motomura et al, 2023, Cancers CrossRef